Konstantinos Oikonomou

Konstantinos Oikonomou

Auto-generated profile, based on publicly available information

Konstantinos Oikonomou

Department of Gastroenterology, University Hospital of Larissa, Mezourlo 1, 41110 Larissa, Greece

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2017 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
KAkonstantinos argyriou
konstantinos argyriou
AKAndreas Kapsoritakis
Andreas Kapsoritakis
KOKonstantinos Oikonomou
Konstantinos Oikonomou
AMAnastasios Manolakis
Anastasios Manolakis
ETEirini Tsakiridou
Eirini Tsakiridou
SPSpyridon Potamianos
Spyridon Potamianos
Background. Inflammatory bowel diseases may cause significant disability. However, little is known regarding the life domains where patients encounter most limitations. Objectives. To assess patients’ overall disability and determine the life domains where most restrictions were applied. Secondarily, we sought for possible relationships among disability, quality of life (HRQoL), and population characteristics. Method. The study lasted for two years (2013–2015) and included 200 patients [52%  ulcerative  colitis  (UC)] from a referral centre. Disability was evaluated using the 36-item version of WHODAS 2.0 questionnaire. The influence of population characteristics on overall disability was assessed with linear regression. Results. Crohn’s disease (CD) patients showed greater overall disability compared to UC (19.22 versus 15.01, p=0.001), with higher scores in the domains of relationships, life activities, and participation. Disability was negatively associated with HRQoL (p<0.001). Long activity, extensive disease, rural residence, and employment independently influenced the overall disability in both groups. Additionally, significant influence was recorded for lower education in the UC and for operation and celibacy in the CD group. Conclusions. CD patients were facing more limitations compared to those with UC, especially in the domains of relationships, activities, and participation. Other than clinical factors, sociodemographic characteristics were also associated with increased disability.

26 April 2017 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
KAkonstantinos argyriou
konstantinos argyriou
EREleftheria Roma
Eleftheria Roma
AKAndreas Kapsoritakis
Andreas Kapsoritakis
ETEirini Tsakiridou
Eirini Tsakiridou
KOKonstantinos Oikonomou
Konstantinos Oikonomou
SPSpyridon Potamianos
Spyridon Potamianos
Background. The rating form of IBD patients’ concerns (RFIPC) provides a unique assessment of the worries and concerns of inflammatory bowel disease (IBD) patients. Our aims were primarily to validate the Greek version of RFIPC and secondarily to describe the pattern of Greek patients’concerns. Methods. After translating RFIPC, the questionnaire was given to IBD patients at baseline and after 12 weeks. The questionnaire’s measuring properties were evaluated based on the consensus-based standards for the selection of health status measurement instruments (COSMIN) recommendations. Premediated factorial structures were tested for goodness of fit with confirmatory factor analysis (CFA). Results. At baseline, 200 patients (94 with Crohn’s disease) completed RFIPC. After 12 weeks, the first 100 patients recompleted the questionnaire. CFA results were consistent with a slightly modified than the original factorial structure. Cronbach’s α and intraclass correlation coefficients were high. RFIPC scores negatively affected the quality of life. RFIPC was sensitive to detect important changes in patients’ condition and was able to discriminate between remission and active disease. Disease activity, full time employment, celibacy, and low education were associated with higher scores. Conclusion. The Greek version of RFIPC is a reliable, valid, and responsive tool to assess Greek IBD patients’ concerns.